Literature DB >> 103496

Inhibition of beta-lactamase in Neisseria gonorrhoeae by sodium clavulanate.

J M Miller, C N Baker, C Thornsberry.   

Abstract

Sodium clavulanate at subinhibitory concentrations affected the activity of penicillin G, ampicillin, or amoxicillin on beta-lactamase-positive strains of Neisseria gonorrhoeae as demonstrated by marked reduction in the minimal inhibitory concentrations of the drugs for the organisms. The compound did not affect the activity of these penicillins on beta-lactamase-negative strains of N. gonorrhoeae. It also had no effect on the activity of cefoxitin against either beta-lactamase-negative or -positive strains. The reduction in minimal inhibitory concentrations of the penicillins for the beta-lactamase-positive organisms brought about by sodium clavulanate is probably due to inhibition of the beta-lactamase by the compound.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103496      PMCID: PMC352554          DOI: 10.1128/AAC.14.5.794

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.

Authors:  C Reading; M Cole
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  Disc agar diffusion antimicrobial susceptibility tests with beta-lactamase producing Neisseria gonorrhoeae.

Authors:  J W Biddle; J M Swenson; C Thornsberry
Journal:  J Antibiot (Tokyo)       Date:  1978-04       Impact factor: 2.649

3.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  W A Ashford; R G Golash; V G Hemming
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

4.  Penicillinase-producing Gonococci in Liverpool.

Authors:  A Percival; J Rowlands; J E Corkill; C D Alergant; O P Arya; E Rees; E H Annels
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

5.  Beta-lactamase-producing, penicillin-resistant gonococcus.

Authors:  I Phillips
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321

6.  National gonorrhea therapy monitoring study: treatment results.

Authors:  R E Kaufman; R E Johnson; H W Jaffe; C Thornsberry; G H Reynolds; P J Wiesner
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

7.  Plasmid-mediated beta-lactamase production in Neisseria gonorrhoeae.

Authors:  L P Elwell; M Roberts; L W Mayer; S Falkow
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

8.  Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.

Authors:  C H O'Callaghan; A Morris; S M Kirby; A H Shingler
Journal:  Antimicrob Agents Chemother       Date:  1972-04       Impact factor: 5.191

9.  Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

  9 in total
  15 in total

1.  Chromosomally mediated intrinsic resistance to penicillin of penicillinase producing strains of Neisseria gonorrhoeae isolated in Sydney: guide to treatment with Augmentin.

Authors:  J W Tapsall; E A Phillips; L M Morris
Journal:  Genitourin Med       Date:  1987-10

2.  Incidence of gonorrhoea due to penicillinase producing Neisseria gonorrhoeae in Japan 1981-3 and treatment using a new antibiotic combination, BRL25000 (amoxycillin and clavulanic acid).

Authors:  K Osato; H Tsugami; K Harada; J Maruyama
Journal:  Genitourin Med       Date:  1986-06

3.  Three regimens of procaine penicillin G, Augmentin, and probenecid compared for treating acute gonorrhoea in men.

Authors:  K B Lim; T Thirumoorthy; C T Lee; E H Sng; T Tan
Journal:  Genitourin Med       Date:  1986-04

Review 4.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila.

Authors:  D J Pohlod; L D Saravolatz; E L Quinn; M M Somerville
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

Review 6.  Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

8.  Two dose Augmentin treatment of acute gonorrhoea in men.

Authors:  K B Lim; V S Rajan; Y C Giam; E O Lui; E H Sng; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-06

9.  First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study.

Authors:  Matitiahu Berkovitch; Orna Diav-Citrin; Revital Greenberg; Michal Cohen; Mordechai Bulkowstein; Svetlana Shechtman; Oxana Bortnik; Judy Arnon; Asher Ornoy
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

Review 10.  The aminopenicillins: development and comparative properties.

Authors:  D S Reeves; D W Bullock
Journal:  Infection       Date:  1979       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.